Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Stevanato Group SpA | STVN | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 27.22 | 04:09:43 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 27.22 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 23.00 - 36.30 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 27.22 | USD |
Stevanato Group SpA Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 8.04B | 295.54M | - | 1B | 142.85M | 0.48 | 56.32 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Stevanato News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical STVN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 29.00 | 29.675 | 26.52 | 27.61 | 463,684 | -1.78 | -6.14% |
| 1 Month | 32.10 | 33.49 | 26.52 | 29.23 | 342,834 | -4.88 | -15.20% |
| 3 Months | 32.05 | 34.73 | 25.52 | 30.58 | 388,104 | -4.83 | -15.07% |
| 6 Months | 31.87 | 34.73 | 23.00 | 29.18 | 342,598 | -4.65 | -14.59% |
| 1 Year | 27.15 | 36.30 | 23.00 | 29.75 | 330,066 | 0.07 | 0.26% |
| 3 Years | 16.65 | 36.30 | 13.355 | 23.08 | 360,659 | 10.57 | 63.48% |
| 5 Years | 16.65 | 36.30 | 13.355 | 23.08 | 360,659 | 10.57 | 63.48% |
Stevanato Description
| Italy-based Stevanato Group is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. Stevanato's revenue is geographically diversified, with 60% of sales from Europe, the Middle East and Africa (EMEA), 27% in North America, 10% in Asia-Pacific (APAC), and 3% in South America. |
